معرفی
Kamyar Asadipooya, MD is an Assistant Professor in the Department of Internal Medicine at the University of Kentucky. His research focuses on endocrine disorders, diabetes, infectious diseases, and bone-related conditions. He has explored the interplay between metabolic syndrome, bone quality in chronic kidney disease (CKD), and the effects of SARS-CoV-2 on endocrine systems. His work includes clinical trials evaluating drug combinations (e.g., spironolactone and sitagliptin) for treating severe COVID-19 cases, as well as systematic reviews analyzing outcomes for patients with type 1 diabetes during the pandemic. Notable studies include investigations into m6A RNA modifications in endocrine pathophysiology and the role of adipokines in metabolic bone diseases.
Dr. Asadipooya’s research also addresses practical clinical challenges, such as optimizing osteoporosis management in CKD patients and evaluating anthropometric indices for predicting metabolic syndrome in elderly populations. He contributes to editorial guidance on bone disorders and has authored case reports on rare conditions like oncocytic osteomalacia and pigmented nodular adrenal hyperplasia. His interdisciplinary approach bridges endocrinology, infectious diseases, and bone biology, with a focus on translational research to improve patient outcomes in complex comorbidities.
His publications span over 20 years of academic work, including studies on transient osteoporosis, mastocytosis-related bone events, and the impact of advanced glycation end products on bone turnover. He collaborates with global institutions on projects such as the Bushehr Elderly Health program, emphasizing community-based epidemiological research. While no scientific awards are explicitly listed, his prolific publication record reflects sustained contributions to clinical and basic science research.
